Your browser doesn't support javascript.
loading
Identification of patients who may benefit the most from adjuvant chemotherapy following resection of incidental gallbladder carcinoma.
Xiang, Jun-Xi; Zhang, Xu-Feng; Weber, Sharon M; Poultsides, George; Fields, Ryan C; Hatzaras, Ioannis; Weiss, Matthew; Scoggins, Charles; Idrees, Kamron; Shen, Perry; Maithel, Shishir K; Pawlik, Timothy M.
Afiliación
  • Xiang JX; Department of Hepatobiliary Surgery, Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Zhang XF; Department of Hepatobiliary Surgery, Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Weber SM; Department of Surgery, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA.
  • Poultsides G; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Fields RC; Department of Surgery, Stanford University Medical Center, Stanford, California, USA.
  • Hatzaras I; Department of Surgery, Washington University School of Medicine, St Louis, Missouri, USA.
  • Weiss M; Department of Surgery, New York University, New York, New York, USA.
  • Scoggins C; Department of Surgery, Northwell Health Cancer Institute, Zucker School of Medicine at Hofstra, Lake Success, New York, USA.
  • Idrees K; Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
  • Shen P; Division of Surgical Oncology, Department of Surgery, University of Louisville, Louisville, Kentucky, USA.
  • Maithel SK; Department of Surgery, Wake Forest University, Winston-Salem, North Carolina, USA.
  • Pawlik TM; Division of Surgical Oncology, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
J Surg Oncol ; 123(4): 978-985, 2021 Mar.
Article en En | MEDLINE | ID: mdl-33497466

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adyuvante / Selección de Paciente / Neoplasias de la Vesícula Biliar Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Surg Oncol Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adyuvante / Selección de Paciente / Neoplasias de la Vesícula Biliar Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Surg Oncol Año: 2021 Tipo del documento: Article